Latest 10-K annual reports
NASDAQ
VYNE Therapeutics announced a definitive merger agreement with Yarrow Biosciences, shifting its strategic focus to Yarrow's clinical-stage TSHR antibody for Graves Disease, following setbacks in its BET inhibitor programs.
NASDAQ
LiqTech International, Inc. reported a 13% revenue increase and improved gross profit for fiscal year 2025, but faces substantial doubt about its ability to continue as a going concern.
NYSE
AXIS Capital achieved a combined ratio of 89.8% and an 18% increase in book value per diluted common share in 2025, driven by profitable underwriting and investment gains.
NYSE
Vishay Precision Group reported a slight revenue increase to $307.2 million in 2025, but net earnings declined to $5.3 million, as the company refined its growth strategy and expanded its senior management team.
NYSE
Alpha Metallurgical Resources, Inc. reported a net loss of $61.7 million for 2025, a significant decline from the prior year, driven by softer metallurgical coal pricing and reduced sales volumes.
NYSE
NATL
Ncr Atleos CORPNCR Atleos Corporation reported a 103% surge in net income to $162 million on a 1% revenue increase to $4.354 billion for fiscal year 2025, alongside a definitive merger agreement with The Brinks Company.
NASDAQ
Enact Holdings, a leading private mortgage insurer, reported a slight dip in 2025 net income and adjusted operating income, alongside increased capital returns and rating upgrades.
NASDAQ
Fulgent Genetics reported a 14% revenue increase to $322.7 million in 2025, alongside a 42% rise in net loss to $60.5 million, driven by strategic acquisitions and R&D investments.
NASDAQ
Treace Medical Concepts, Inc. reported a net loss of $59.0 million for fiscal year 2025, despite a slight revenue increase and new product introductions in the competitive bunion correction market.
NYSE
NIQ Global Intelligence plc reported significant revenue growth and improved profitability in 2025, driven by strategic investments in AI and successful post-IPO debt refinancing.
NASDAQ
ANI Pharmaceuticals achieved significant revenue and net income growth in 2025, fueled by the successful integration of Alimera Sciences and key product expansions.
NYSE
DINO
Hf Sinclair CORPHF Sinclair Corporation reported a significant increase in net income for 2025, driven by improved refining margins and small refinery RINs waivers, despite leadership changes and ongoing regulatory challenges.
NYSE
MATX
Matson, INCMatson, Inc. reports a 2.3% decrease in total operating revenue for 2025, driven by lower China volume, while advancing a $1.0 billion fleet renewal program and maintaining a strong balance sheet.
NASDAQ
Oportun Financial Corporation reported a net income of $25.2 million for fiscal year 2025, driven by increased loan originations and reduced operating expenses, despite a slight decline in total revenue.
NYSE
Smurfit Westrock reported a significant increase in net sales and net income for 2025, largely driven by the WestRock acquisition and achievement of synergy targets.
NASDAQ
Marten Transport, Ltd. reported an 8.3% decrease in operating revenue and a 35.2% decline in net income for fiscal year 2025, alongside the sale of its Intermodal operations.
NASDAQ
Mister Car Wash, Inc. announced a definitive merger agreement to be acquired by affiliates of Leonard Green & Partners, L.P. for $7.00 per share in cash, with the company reporting strong 2025 financial performance.
NYSE
10-K: Compass Diversified Holdings Files 2025 10-K, Details Lugano Bankruptcy & Financial Restatement
Compass Diversified Holdings reported a net loss of $293.7 million for 2025, driven by the deconsolidation of its Lugano subsidiary following its Chapter 11 bankruptcy filing and significant costs from an internal investigation and financial restatement.
NYSE
American Integrity Insurance Group, Inc. reported substantial growth in policies and net income for 2025, driven by strategic Citizens take-outs and improved Florida market conditions.
NASDAQ
Golden Entertainment, Inc. reported a net loss of $6.043 million for the fiscal year ended December 31, 2025, driven by decreased revenues across its segments, while progressing with a definitive agreement to sell most operating and real estate assets.
NYSE
Arlo Technologies reported a significant financial turnaround in 2025, achieving net income of $14.9 million, primarily fueled by robust growth in its subscription services.
OTC.Pink
ACZT
Aceztech CORPHuineng Technology Corporation's latest 10-K filing reveals a significant revenue decline and ongoing net losses, raising substantial doubt about its ability to continue as a going concern.
NASDAQ
NTRA
Natera, INCNatera, Inc. reported significant revenue growth in 2025, driven by increased test volumes across its oncology, women's health, and organ health segments, alongside strategic acquisitions and facility expansions.
NASDAQ
Alignment Healthcare reports significant revenue and membership growth, dramatically reducing net loss and boosting Adjusted EBITDA in its 2025 annual filing.
NYSE
PACS
Pacs Group, INCPACS Group, a leading post-acute healthcare provider, announced significant revenue and net income growth for 2025, while navigating multiple ongoing regulatory and legal investigations.
NYSE
Kennedy-Wilson Holdings, Inc. reported a reduced net loss for 2025, driven by increased investment management fees and fair value gains, while progressing its take-private merger agreement.
Alexander & Baldwin, a Hawaii-focused REIT, reported mixed financial results for 2025 with a pending merger expected to close in Q1 2026 at $21.20 per share.
NYSE
Excelerate Energy achieved significant revenue and profit growth in 2025, driven by the Jamaica acquisition and new LNG projects, while expanding its global infrastructure.
NYSE
Live Oak Bancshares achieved record loan production and significant net income growth in 2025, despite identifying a material weakness in internal financial reporting controls and an increase in nonperforming assets.
NASDAQ
Nexstar Media Group reports a decrease in 2025 net revenue to $4.9 billion, driven by lower advertising, while advancing its $6.2 billion TEGNA acquisition expected to close by H2 2026.